Jacobs Engineering Group
J
$126.46
+0.51%
Jacobs Solutions Inc. is a global provider of engineering, design, procurement, construction, and maintenance services, operating within the Industrials sector's Engineering & Construction industry. The company is a major player in the professional services landscape, distinguished by its broad portfolio that includes critical infrastructure projects and cyber engineering solutions for government, industrial, and commercial clients. The current investor narrative is shaped by a significant stock price decline over the past six months, contrasting with reported revenue growth, leading to a debate over whether the market is overly discounting its fundamentals or correctly pricing in future headwinds in its cyclical end markets.…
J
Jacobs Engineering Group
$126.46
Investment Opinion: Should I buy J Today?
Rating & Thesis: Hold. Jacobs Solutions presents a conflicted picture where solid fundamentals (strong FCF, revenue growth) are overshadowed by severe technical damage and earnings volatility, making immediate catalysts for a re-rating unclear. The mixed analyst sentiment, with a recent downgrade to Neutral offset by maintained Outperform ratings, reflects this uncertainty.
Supporting Evidence: The primary valuation metric, the forward P/E of 15.78x, is reasonable and suggests the stock is not egregiously overvalued if forward EPS of $9.02 is achieved. Revenue growth remains positive at 12.3% YoY, and the company generates exceptional free cash flow ($875M TTM), providing financial resilience. However, the stock trades just 9% above its 52-week low after a 20.7% six-month decline, and net margin volatility (Q1 2026: 4.04%) introduces uncertainty into those forward earnings estimates.
Risks & Conditions: The two biggest risks are 1) a breakdown below the $116.20 support level confirming the downtrend, and 2) a deceleration in revenue growth below 10% or further margin compression invalidating the forward earnings estimates. This Hold rating would upgrade to a Buy if the stock demonstrates sustained technical recovery above $140, coupled with evidence of margin stabilization in the next earnings report. It would downgrade to a Sell on a confirmed break below $116.20 or if quarterly revenue growth decelerates to mid-single digits. The stock is currently fairly valued relative to its forward earnings potential but undervalued relative to its own historical price range, creating a stalemate that warrants a neutral stance.
Sign up to view all
J 12-Month Price Forecast
The outlook for Jacobs is one of high uncertainty balanced by compressed valuation. The base case (55% probability) of range-bound trading is most likely, as the stock digests its sharp decline while fundamentals play out. The substantial free cash flow and reasonable forward multiple provide a floor, but the lack of positive momentum and earnings volatility cap the upside. The stance is neutral because the compelling value argument (low price, high FCF) is counteracted by clear technical and sentiment headwinds. An upgrade to bullish would require consecutive quarters of margin stability and revenue growth acceleration, while a downgrade to bearish would be triggered by a breakdown below $116 support or a significant earnings miss.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Jacobs Engineering Group's 12-month outlook, with a consensus price target around $164.40 and implied upside of +30.0% versus the current price.
Average Target
$164.40
4 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
4
covering this stock
Price Range
$101 - $164
Analyst target range
Analyst coverage for Jacobs is limited, with only 4 analysts providing estimates, which is low for a company of its market cap ($17.8 billion) and suggests it may be under-followed by the broader institutional research community. The consensus recommendation cannot be definitively determined from the provided data, but recent institutional ratings show a mix of actions: following the Q4 2025 report in November, firms like Baird downgraded from 'Outperform' to 'Neutral', while RBC Capital maintained 'Outperform' and Citigroup maintained 'Buy'. This indicates a cautious to neutral sentiment shift among some analysts. The average revenue estimate for the forward period is $10.70 billion, with a wide range from $10.22 billion to $11.14 billion. The wide range between the low and high revenue estimates ($10.22B to $11.14B) signals high uncertainty among analysts regarding the company's near-term growth trajectory. The high estimate likely assumes successful execution on large projects and stable demand across its end markets, while the low estimate may price in potential project delays or a sharper economic slowdown impacting capital expenditures. The recent downgrade by Baird to 'Neutral' specifically points to concerns that may be tempering bullish outlooks. Limited coverage can lead to higher stock price volatility and less efficient price discovery, as fewer institutional voices are shaping the consensus view.
Bulls vs Bears: J Investment Factors
The evidence currently tilts bearish, primarily due to the stock's persistent technical breakdown and negative momentum, which outweighs its solid fundamental underpinnings. The bear case is supported by the severe 20.7% six-month decline, negative relative strength, and recent analyst downgrades signaling a loss of confidence. The bull case rests on a reasonable forward valuation of 15.8x P/E, robust free cash flow of $875M, and a deep discount to its 52-week high. The single most important tension in the investment debate is whether the market's sharp discounting of the stock (trading near 52-week lows) is an overreaction to cyclical fears and earnings volatility, or a correct pre-emptive pricing of a fundamental slowdown that the 12.3% YoY revenue growth has yet to reflect. The resolution hinges on the sustainability of revenue growth and margin stability in upcoming quarters.
Bullish
- Strong Free Cash Flow Generation: The company generated $875.3 million in trailing twelve-month free cash flow, significantly exceeding its net income. This robust cash generation provides a strong financial foundation, funding a 0.86% dividend yield with a 52.7% payout ratio and enabling potential share buybacks without straining the balance sheet.
- Reasonable Forward Valuation: Despite a distorted trailing P/E of 61.17x, the forward P/E is a much more reasonable 15.78x. This forward multiple, based on analyst EPS estimates of $9.02, suggests the market is not pricing in excessive growth and offers a potential entry point if earnings materialize as expected.
- Solid Revenue Growth: Q1 2026 revenue grew 12.3% year-over-year to $3.29 billion, demonstrating continued demand for its services. This growth is anchored by the dominant Infrastructure & Advanced Facilities segment, which contributed $2.94 billion in the quarter.
- Healthy Balance Sheet: Jacobs maintains a current ratio of 1.30 and a moderate debt-to-equity ratio of 0.74. This financial stability, coupled with strong cash flow, mitigates liquidity risk and provides flexibility to navigate cyclical downturns in its end markets.
Bearish
- Severe Technical Downtrend: The stock is down 20.67% over six months and 8.19% over three months, with a maximum drawdown of -25.28%. It has shown severe negative relative strength of -11.29 points vs. the S&P 500 over the past month, indicating persistent selling pressure and a lack of near-term catalysts.
- Earnings Volatility and Margin Pressure: Net margins have been volatile, ranging from 6.15% in Q3 2025 to 4.04% in Q1 2026. The Q1 gross margin of 23.24% is below the TTM gross margin of 24.81%, indicating potential cost pressures or unfavorable project mix that could compress profitability.
- High Trailing P/E and Price-to-Book: The trailing P/E of 61.17x is extremely elevated, and the Price-to-Book ratio of 4.88x is high relative to its historical range of 2-4x. These metrics signal that the stock is expensive on a reported earnings basis and that the market still assigns a premium, which could compress further.
- Limited Analyst Coverage and Downgrades: Only 4 analysts cover the stock, suggesting it is under-followed and prone to inefficient price discovery. Recent sentiment has turned cautious, with Baird downgrading from 'Outperform' to 'Neutral' post-Q4 2025 earnings, reflecting concerns about future performance.
J Technical Analysis
The stock is in a pronounced downtrend, having declined 20.67% over the past six months and 8.19% over the last three months, culminating in a current price of $126.60. This price sits just 9.0% above its 52-week low of $116.20, positioning it in the lower decile of its 52-week range ($116.20 to $168.44), which typically signals either a deep value opportunity or a stock in a persistent downtrend with further downside risk. Recent momentum shows continued weakness, with the stock down 2.59% over the past month, a period during which the broader market (SPY) gained 8.7%, resulting in severe negative relative strength of -11.29 points. This divergence from the market's positive momentum underscores significant stock-specific selling pressure and a lack of near-term catalysts for recovery. Key technical levels are clearly defined, with immediate support at the 52-week low of $116.20 and major resistance at the 52-week high of $168.44. A decisive breakdown below $116.20 would likely trigger another leg down, while a sustained move above the recent recovery highs near $151 would be needed to signal a potential trend reversal. The stock's beta of 0.752 indicates it is about 25% less volatile than the broader market, which is notable given its sharp decline; this lower beta suggests the sell-off has been driven more by fundamental or sector-specific concerns than broad market risk-off sentiment, but it also implies less potential for a sharp, beta-driven rebound if the market rallies. The stock's volatility is further evidenced by a maximum drawdown of -25.28% over the provided period, and its current price is a significant 24.8% below its 52-week high. The combination of a low beta and high drawdown points to idiosyncratic risk. The substantial gap between the current price and the 52-week high of $168.44 represents a 24.8% decline, highlighting the depth of the correction and the considerable upside potential required for a full recovery, which would demand a fundamental re-rating.
Beta
0.75
0.75x market volatility
Max Drawdown
-25.3%
Largest decline past year
52-Week Range
$116-$168
Price range past year
Annual Return
+3.3%
Cumulative gain past year
| Period | J Return | S&P 500 |
|---|---|---|
| 1m | +0.5% | +12.2% |
| 3m | -7.5% | +2.3% |
| 6m | -20.1% | +4.7% |
| 1y | +3.3% | +29.2% |
| ytd | -6.6% | +4.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
J Fundamental Analysis
Revenue growth remains positive but shows signs of deceleration. The most recent quarterly revenue (Q1 2026) was $3.29 billion, representing a solid 12.3% year-over-year growth from the $2.93 billion in Q1 2025. However, examining the sequential trend from the prior three quarters reveals volatility: Q4 2025 revenue was $3.15 billion, Q3 2025 was $3.03 billion, and Q2 2025 was $2.91 billion. The Infrastructure & Advanced Facilities segment, at $2.94 billion, is the dominant revenue driver, while the PA Consulting segment contributed $354 million. The 12.3% YoY growth is healthy, but investors will monitor for sustainability amid economic cyclicality. Profitability is present but margins are under pressure. The company reported net income of $133.2 million for Q1 2026, with a net margin of 4.04%. Gross margin for the quarter was 23.24%, which is below the trailing twelve-month gross margin of 24.81% indicated in the valuation data, suggesting some compression. Operating margin was 7.06% for the quarter. Comparing to the previous quarter (Q4 2025), net income was $110.7 million with a net margin of 3.51%, and the quarter before that (Q3 2025) showed a stronger net income of $186.2 million with a 6.15% net margin. This indicates net margin volatility quarter-to-quarter, though the company remains solidly profitable. The balance sheet and cash flow position appear robust. The company maintains a healthy current ratio of 1.30 and a moderate debt-to-equity ratio of 0.74. Most notably, it generated substantial free cash flow of $875.3 million on a trailing twelve-month basis. Return on Equity (ROE) is 7.97%, and Return on Assets (ROA) is 5.69%, indicating efficient but not exceptional use of capital. The strong free cash flow, which significantly exceeds net income, provides ample liquidity for funding operations, dividends (payout ratio of 52.7%), and share repurchases without reliance on excessive external debt, underpinning financial stability.
Quarterly Revenue
$3.3B
2025-12
Revenue YoY Growth
+0.12%
YoY Comparison
Gross Margin
+0.23%
Latest Quarter
Free Cash Flow
$875288000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is J Overvalued?
Given the company's positive net income, the primary valuation metric selected is the Price-to-Earnings (PE) ratio. The trailing PE ratio is exceptionally high at 61.17x, which is distorted by potentially low earnings in the measurement period, while the forward PE is a much more reasonable 15.78x. This massive gap implies the market expects a significant recovery in earnings over the next twelve months, with forward estimates baking in substantial profit growth or normalization. Compared to industry averages, Jacobs trades at a premium on a sales basis but the forward PE suggests a more reasonable valuation. The Price-to-Sales (PS) ratio is 1.48x, and the Enterprise Value-to-Sales (EV/Sales) is 1.41x. Without a provided industry average, we can note that a PS ratio around 1.5x is not excessive for a stable engineering services firm. The forward PE of 15.8x is likely in line with or at a modest premium to industrials peers, justified by its strong free cash flow generation and market leadership position. Historically, the stock's own valuation has compressed significantly. The current trailing PE of 61.17x is an outlier compared to its recent historical range; for instance, the PE ratio was 40.08x at the end of Q4 2025 and 30.11x at the end of Q1 2026 (per historical ratios data). The current high trailing multiple is more a function of depressed earnings in the denominator rather than an inflated stock price. The Price-to-Book ratio of 4.88x remains elevated compared to historical levels near 2-4x over the past few years, suggesting the market still assigns a premium to its equity base. The stock is not near its own historical valuation highs when considering forward earnings, indicating expectations are tempered.
PE
61.2x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -229x~654x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
20.7x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Jacobs faces risks from earnings volatility, as evidenced by net margins swinging from 6.15% to 4.04% over recent quarters, and potential margin compression with Q1 gross margin of 23.24% below its TTM average. While the balance sheet is healthy (D/E of 0.74), the company's valuation is highly sensitive to earnings delivery; the forward P/E of 15.8x embeds significant profit growth expectations. A failure to meet these estimates could trigger multiple compression. Revenue, though growing at 12.3% YoY, shows sequential volatility, indicating potential lumpiness in project awards and execution.
Market & Competitive Risks: The stock trades at a premium on a Price-to-Book basis (4.88x vs. historical 2-4x range) and carries a high trailing P/E of 61.17x, making it vulnerable to valuation compression if growth stock multiples contract or if sector rotation away from industrials occurs. Its beta of 0.752 indicates it is less volatile than the market, but the 25.3% max drawdown shows it has significant idiosyncratic risk, likely tied to project-specific or sector concerns. Competitive pressures in engineering services could pressure bid margins, and a macroeconomic slowdown would directly impact its cyclical end markets like infrastructure and facilities.
Worst-Case Scenario: The worst-case scenario involves a combination of a sharp economic downturn leading to project cancellations, continued margin compression eroding the forward earnings estimates, and a loss of investor confidence triggering a re-rate to its historical lower valuation range. This could see the stock break below its key technical support at the 52-week low of $116.20. A realistic downside from the current price of $126.60 would be a decline of approximately -8% to that support level, with the potential for a further drop towards $110 if the bear case fully materializes, representing a total loss of around -13% from current levels. The limited analyst coverage (4 firms) could exacerbate selling if negative news emerges, due to a thinner base of supportive research.
FAQ
The key risks are: 1) Cyclical and Execution Risk: Exposure to economic cycles impacting capital spending, coupled with volatile quarterly margins (e.g., Q1 net margin of 4.04%). 2) Technical and Sentiment Risk: The stock is in a severe downtrend, down 20.7% in six months with negative relative strength, indicating persistent selling pressure. 3) Valuation Compression Risk: High trailing P/E and P/B ratios make the stock vulnerable to de-rating if growth disappoints. 4) Coverage Risk: Being followed by only 4 analysts increases the potential for sharp moves on company-specific news due to less institutional research support.
The 12-month forecast presents three scenarios. The base case (55% probability) sees the stock trading between $130 and $150 as it digests recent losses, assuming it meets revenue estimates near $10.7B. The bull case (25% probability), targeting $155-$168, requires earnings beats and a sentiment reversal. The bear case (20% probability), targeting $110-$120, involves an economic slowdown breaking key support. The base case is most likely, implying a modest potential upside from the current $126.60 but within a wide range, with the key assumption being that forward EPS estimates of $9.02 are achieved.
J's valuation is mixed. It appears significantly overvalued on a trailing P/E basis at 61.17x, but this is distorted by low earnings in the measurement period. On a forward-looking basis, it is fairly valued or slightly undervalued with a forward P/E of 15.78x, which is reasonable for a stable industrial company. Compared to its own history, the stock is undervalued relative to its 52-week high (discount of 24.8%), but the elevated Price-to-Book ratio of 4.88x suggests the market still assigns a premium to its equity. Overall, the forward multiple implies the market expects moderate growth, not irrational exuberance.
J is a conflicted buy at present. For a patient value investor, the current price near 52-week lows and a reasonable forward P/E of 15.8x could represent a good entry point, especially given its strong $875M free cash flow. However, for most investors, it is not a compelling buy today due to the clear downtrend, negative momentum, and earnings volatility. It could become a good buy if it shows technical stabilization above support and delivers consistent margins in the next quarter. The limited analyst coverage adds an element of uncertainty to the investment thesis.
J is more suitable for a long-term investment horizon of 2-3 years. Its low beta of 0.75 means it is unlikely to see sharp, short-term rebounds, and the current technical downtrend lacks near-term catalysts. Long-term investors can look through the cyclical volatility to capture the value from its strong cash flow generation and market position, while also collecting a modest 0.86% dividend. Short-term traders should avoid it due to its weak momentum and the high risk of being caught in a continued range-bound or declining pattern. A minimum holding period of 12-18 months is suggested to allow for a potential fundamental re-assessment by the market.
